Exosomal ANXA6 from gemcitabine-resistant cells induced gemcitabine resistance in sensitive triple negative breast cancer (TNBC) cells, at least by downregulating EGFR (Li T. et al., 2021). The gene discussed is ANXA6; the disease is triple-negative breast carcinoma.